Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 2020The Journal of Infectious DiseasesOpen Access

Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome–Coronavirus 2 In Vitro When Administered After Virus Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

NCNicola ClementiRFRoberto FerrareseECElena Criscuolo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clementi et al. (2020) studied this question.

synapsesocial.com/papers/6a73a33d8412e8bdfca7315chttps://doi.org/10.1093/infdis/jiaa350
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interferon-α2b treatment for COVID-192020 · 58 citations
  2. 2Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates2010 · 350 citations
  3. 3Interferon-α2b Treatment for COVID-192020 · 389 citations
  4. 4Interferon-β 1a and SARS Coronavirus Replication2004 · 187 citations
  5. 5SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology2020 · 648 citations